Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 6, 2010

View Archived Issues

Nanotherapeutics submits IND to FDA for radiation exposure candidate

French scientists identify NTNG1 gene polymorphisms linked to alcohol and cocaine codependence

New MCH1 receptor antagonists claimed by sanofi-aventis

AstraZeneca's new TRPV1 antagonists inhibit capsaicin-evoked pain and flare

Atopaxar may reduce major cardiac events in subjects with ACS and CAD

Sanofi-aventis updates progress of second quarter 2010

Amgen discloses new selective inhibitors of hepatocyte growth factor receptor

Studies evaluate tamsulosin and doxazosin for urolithiasis

Czech scientists discover new antimicrobial peptides

Abbott presents new GlyT-1 inhibitors

Celldex to regain worldwide rights to rindopepimut from Pfizer

Merck & Co. describes novel gamma-secretase inhibitors

New activators of AMPK subunit alpha-1 claimed by Betagenon

INT-007 is bioequivalent to branded tablet for erectile dysfunction

Gilead submits MAA for fixed-dose Truvada/TMC-278 combination for HIV infection

Eisai launches Glufast in China for type 2 diabetes

Gynecologic Oncology Group to begin phase II trial of paclitaxel/ReoT3D combination

Johnson & Johnson submits MAA to EMA for TMC-278 for HIV infection

University of Rochester Medical Center begins study of muscular dystrophy therapeutics

Cladribine tablets are approved in Australia for MS

MSD and Faes Farma to market sitagliptin and sitagliptin/metformin in Spain

Levitra orodispersible tablet is approved in Europe for erectile dysfunction

EHDN supports statistical conclusions on MermaiHD trial's primary endpoint

ImmunoCellular Therapeutics presents update on ICT-107 and ICT-69

GSK investigates reports of narcolepsy following Pandemrix vaccination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
DOJ arrests shed light on Medicare skin substitute controversy
BioWorld MedTech
Much has been made of the recent skyrocketing of Medicare spending on skin substitutes, but a new enforcement action by the U.S. Department of Justice might help...